Tone Yrvum new CEO for Oslo Cancer Cluster
Tone Yrvum, new CEO for Oslo Cancer Cluster. Photo: MoleGenetics
Tone Yrvum (42) has been chosen as new CEO for Oslo Cancer Cluster. Yrvum has a broad background and experience from the biotech industry.
Tone Yrvum comes from a position as Sales- and marketing director in Mole Genetics, a company she co-founded some years ago. Yrvum holds a Master in Science and a Master of Business Administration. She has previously been working in both Dynal Biotech and Invitrogen. Read more atOslo Cancer Cluster's website.